Regentatlantic Capital LLC Pfizer Inc Call Options Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PFE
# of Institutions
3,253Shares Held
3.72BCall Options Held
73.5MPut Options Held
108M-
Vanguard Group Inc Valley Forge, PA511MShares$14 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.7 Billion0.27% of portfolio
-
State Street Corp Boston, MA287MShares$7.88 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA166MShares$4.57 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA117MShares$3.22 Billion0.63% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $154B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...